Market Currents
Amgen (AMGN +0.3%) bucks a weak tape on positive comments out of Baird this morning ahead of its...
-
Monday, July 16, 2012, 10:39 AM ETAmgen (AMGN +0.3%) bucks a weak tape on positive comments out of Baird this morning ahead of its Q2 report. The firm says it's anticipating the company to beat expectations, citing its strong operational upside and insulation from weak macro conditions. Stock momentum should also be aided by additional stockholder incentives such as dividend raises and buybacks, and it raises its price target to $79 from $75.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
